Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus

References

• Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321. doi:10.1016/j.diabres.2011.10.029
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar
• Ahlqvist E, van Zuydam NR, Groop LC, McCarthy MI. The genetics of diabetic complications. Nat Rev Nephrol. 2015;11(5):277–287. doi:10.1038/nrneph.2015.37
   PubMed Web of Science ®Google Scholar
• van der Greef J, Davidov E, Verheij E, et al. The role of metabolomics in systems biology. In: Harrigan GG, Goodacre R, editors. Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Boston, MA: Springer US; 2003:171–198.
   Google Scholar
• Kaur P, Rizk NM, Ibrahim S, et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. J Proteome Res. 2012;11(11):5527–5539. doi:10.1021/pr300798z
   PubMedGoogle Scholar
• Kaur P, Rizk N, Ibrahim S, et al. Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes. Mol Biosyst. 2013;9(2):307–317. doi:10.1039/c2mb25384d
   PubMedGoogle Scholar
• American Diabetes A. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36(Suppl 1):S11–66. doi:10.2337/dc13-S011
   PubMedGoogle Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499
   PubMed Web of Science ®Google Scholar
• Derbala M, Rizk N, Al-Kaabi S, et al. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment. J Viral Hepat. 2009;16(10):689–696. doi:10.1111/j.1365-2893.2009.01096.x
   PubMedGoogle Scholar
• Rizk NM, El-Menyar A, Marei I, et al. Association of adiponectin gene polymorphism (+ T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 2013;64(4):257–265. doi:10.1177/0003319712455497
   PubMedGoogle Scholar
• Zhao Z, Xu Y. An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J Lipid Res. 2010;51(3):652–659. doi:10.1194/jlr.D001503
   PubMed Web of Science ®Google Scholar
• Cham BE, Knowles BR. A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res. 1976;17(2):176–181.
   PubMed Web of Science ®Google Scholar
• Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779–787. doi:10.1021/ac051437y
   PubMed Web of Science ®Google Scholar
• Cui Q, Lewis IA, Hegeman AD, et al. Metabolite identification via the madison metabolomics consortium database. Nat Biotechnol. 2008;26(2):162–164. doi:10.1038/nbt0208-162
   PubMed Web of Science ®Google Scholar
• Forsythe IJ, Wishart DS. Exploring human metabolites using the human metabolome database. In: Current Protocols in Bioinformatics. John Wiley & Sons, Inc; 2002.
   Google Scholar
• Sud M, Fahy E, Cotter D, et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 2007;35(Database issue):D527–532. doi:10.1093/nar/gkl838
   PubMed Web of Science ®Google Scholar
• Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and Diabetes. The Good, the Bad, or the Indifferent?. 2005;54(suppl 2):S114–S124. doi:10.2337/diabetes.54.suppl_2.S114
   Google Scholar
• Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm. 2009;80:613–633. doi:10.1016/s0083-6729(08)00621-3
   PubMed Web of Science ®Google Scholar
• Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. In: Pedersen SHF, Cordat E, Barber DL, et al, editors. Reviews of Physiology, Biochemistry and Pharmacology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2004:1–38.
   Google Scholar
• Yang X, Huo F, Liu B, et al. Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of PI3K/Akt signaling pathway. Journal of Molecular Neuroscience. 2017;61(4):581–589. doi:10.1590/s0100-879x2006005000143
   PubMed Web of Science ®Google Scholar
• Hers I, Vincent EE, Tavare JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515–1527. doi:10.1016/j.cellsig.2011.05.004
   PubMed Web of Science ®Google Scholar
• Kane S, Sano H, Liu SCH, et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem. 2002;277(25):22115–22118. doi:10.1074/jbc.C200198200
   PubMedGoogle Scholar
• Zhang P, Gao J, Pu C, Zhang Y. Apolipoprotein status in type 2 diabetes mellitus and its complications (Review). Mol Med Rep. 2017;16(6):9279–9286. doi:10.3892/mmr.2017.7831
   PubMedGoogle Scholar
• Patel HJ, Patel BM. TNF-alpha and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56–63. doi:10.1016/j.lfs.2016.11.033
   PubMed Web of Science ®Google Scholar
• Claudel T, Staels B, Kuipers F. The Farnesoid X receptor. Arterioscler Thromb Vasc Biol. 2005;25(10):2020–2030. doi:doi:10.1161/01.ATV.0000178994.21828.a7
   PubMed Web of Science ®Google Scholar
• Pols TW, Auwerx J, Schoonjans K. Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease. Gastroenterol Clin Biol. 2010;34(4–5):270–273. doi:10.1016/j.gcb.2010.03.009
   PubMedGoogle Scholar
• Sun C, Wu Q, Zhang X, He Q, Zhao H Mechanistic evaluation of the protective effect of carnosine on acute lung injury in sepsis rats. Pharmacology. 2017;100(5–6):292–300. doi:10.1159/000479879
   PubMedGoogle Scholar
• Kamiyama M, Urushihara M, Morikawa T, et al. Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci. 2013;14(11):23045–23062. doi:10.3390/ijms141123045
   PubMedGoogle Scholar
• Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study. BMC nephrology. 2017;18(1):11. doi:10.1186/s12882-016-0429-x
   PubMedGoogle Scholar
• Chow J, Hartley R, Jagger C, Dilly S ICAM-1 expression in renal disease. Journal of clinical pathology. 1992;45(10):880–884. doi:10.1136/jcp.45.10.880
   PubMedGoogle Scholar
• Vielhauer V, Mayadas TN Functions of TNF and its Receptors in Renal Disease: Distinct Roles in Inflammatory Tissue Injury and Immune Regulation. Seminars in nephrology. 2007: Elsevier. doi:10.1016/j.semnephrol.2007.02.004
   Google Scholar
• Chen YW, Yang CY, Huang CF, Hung DZ, Leung YM, Liu SH. Heavy metals, islet function, and diabetes development. Islets. 2009;1(3):169–176. doi:10.4161/isl.1.3.9262
   PubMed Web of Science ®Google Scholar
• Bonaventura P, Lamboux A, Albarède F, Miossec P. Differential effects of TNF-α and IL-1β on the control of metal metabolism and cadmium-induced cell death in chronic inflammation. PLoS One. 2018;13(5):e0196285. doi:10.1371/journal.pone.0196285
   PubMedGoogle Scholar
• Smith-Palmer J, Brändle M, Trevisan R, Orsini Federici M, Liabat S, Valentine W. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(3):273–284. doi:10.1016/j.diabres.2014.06.007
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546–551. doi:10.4103/2230-8210.183480
   PubMedGoogle Scholar
• Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–2443. doi:10.1093/eurheartj/eht149
   PubMed Web of Science ®Google Scholar
• Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50(5):567–575. doi:10.1016/j.freeradbiomed.2010.12.006
   PubMed Web of Science ®Google Scholar
• Zhu X, Zheng X, Wu Y. Cleaved high molecular weight kininogen stimulates JNK/FOXO4/MnSOD pathway for induction of endothelial progenitor cell senescence. Biochem Biophys Res Commun. 2014;450(4):1261–1265. doi:10.1016/j.bbrc.2014.06.112
   PubMedGoogle Scholar
• Wilson SH, Ljubimov AV, Morla AO, et al. Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through alpha5beta1 integrin and PI 3-kinase. Invest Ophthalmol Vis Sci. 2003;44(4):1704–1715. doi:10.1167/iovs.02-0773
   PubMedGoogle Scholar
• Popov D. Endothelial cell dysfunction in hyperglycemia: phenotypic change, intracellular signaling modification, ultrastructural alteration, and potential clinical outcomes. Int J Diabetes Mellit. 2010;2(3):189–195. doi:10.1016/j.ijdm.2010.09.002
   Google Scholar
• Del Rosso M, Fibbi G, Pucci M, Margheri F, Serrati S. The plasminogen activation system in inflammation. Front Biosci. 2008;13(13):4667–4686. doi:10.2741/3032
   PubMedGoogle Scholar
• Marchesi M, Booth EA, Rossoni G, et al. Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart. Atherosclerosis. 2008;197(2):572–578. doi:10.1016/j.atherosclerosis.2007.08.028
   PubMedGoogle Scholar
• Filkova M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133(2):157–170. doi:10.1016/j.clim.2009.07.013
   PubMed Web of Science ®Google Scholar
• Merlini G, Seldin DC, Gertz MA. Amyloidosis: Pathogenesis and New Therapeutic Options. Journal of Clinical Oncology. 2011;29(14):1924. doi:10.1200/JCO.2010.32.2271
   PubMed Web of Science ®Google Scholar
• Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109(2):143–159. doi:10.1042/CS20050025
   PubMed Web of Science ®Google Scholar
• Gandhi J, Dagur G, Warren K, Smith NL, Khan SA. Genitourinary Complications of Diabetes Mellitus: An Overview of Pathogenesis, Evaluation, and Management. Curr Diabetes Rev. 2017;13(5):498–518. doi:10.2174/1573399812666161019162747
   PubMedGoogle Scholar
• Alba-Loureiro TC, Munhoz CD, Martins JO, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007;40(8):1037–1044. doi:10.1590/s0100-879x2006005000143
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006;17(2):368–377. doi:10.1681/ASN.2005080859
   PubMed Web of Science ®Google Scholar
• Ay L, Hoellerl F, Ay C, et al. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease. Eur J Clin Invest. 2012;42(5):470–477. doi:10.1111/j.1365-2362.2011.02602.x
   PubMedGoogle Scholar
• Herder C, Karakas M, Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther. 2011;90(1):52–66. doi:10.1038/clpt.2011.93
   PubMed Web of Science ®Google Scholar
• Pradhan L, Cai X, Wu S, et al. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res. 2011;167(2):336–342. doi:10.1016/j.jss.2009.09.012
   PubMedGoogle Scholar
• Premilovac D, Attrill E, Rattigan S, Richards SM, Kim J, Keske MA. Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle. Cardiovasc Res. 2019;115(3):590–601. doi:10.1093/cvr/cvy225
   PubMedGoogle Scholar
• Quiroga DT, Munoz MC, Gil C, et al. Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice. Physiol Rep. 2018;6(16):e13824. doi:10.14814/phy2.13824
   PubMedGoogle Scholar
• Dominici FP, Burghi V, Munoz MC, Giani JF. Modulation of the action of insulin by angiotensin-(1–7). Clin Sci. 2014;126(9):613–630. doi:10.1042/CS20130333
   Google Scholar
• Lyu J, Imachi H, Fukunaga K, et al. Angiotensin II induces cholesterol accumulation and impairs insulin secretion by regulating ABCA1 in beta cells. J Lipid Res. 2018;59(10):1906–1915. doi:10.1194/jlr.M085886
   PubMed Web of Science ®Google Scholar
• Oberoi R, Schuett J, Schuett H, et al. Targeting tumor necrosis factor-α with adalimumab: effects on endothelial activation and monocyte adhesion. PLoS One. 2016;11(7):e0160145–e0160145. doi:10.1371/journal.pone.0160145
   PubMedGoogle Scholar
• Oike T, Sato Y, Kobayashi T, et al. Stat3 as a potential therapeutic target for rheumatoid arthritis. Sci Rep. 2017;7(1):10965. doi:10.1038/s41598-017-11233-w
   PubMedGoogle Scholar
• Dutzmann J, Daniel JM, Bauersachs J, Hilfiker-Kleiner D, Sedding DG. Emerging translational approaches to target STAT3 signalling and its impact on vascular disease. Cardiovasc Res. 2015;106(3):365–374. doi:10.1093/cvr/cvv103
   PubMed Web of Science ®Google Scholar
• Chiba T, Yamada M, Aiso S. Targeting the JAK2/STAT3 axis in Alzheimer's disease. Expert Opin Ther Targets. 2009;13(10):1155–1167. doi:10.1517/14728220903213426
   PubMed Web of Science ®Google Scholar
• Nakamura K, Watanabe H, Miyazaki J, et al. Discovery of New Hydrothermal Activity and Chemosynthetic Fauna on the Central Indian Ridge at 18°–20°S. PLOS ONE. 2012;7(3):e32965. doi:10.1371/journal.pone.0032965
   PubMed Web of Science ®Google Scholar
• Chida R, Hisauchi I, Toyoda S, et al. Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients. Hypertens Res. 2015;38(11):765–769. doi:10.1038/hr.2015.82
   PubMed Web of Science ®Google Scholar